MRVI

MARAVAI LIFESCIENCES HOLDINGS, INC.

Nasdaq · Pharmaceutical Preparations · Inc. DE · CIK 0001823239
$5.01 +1.01% $1.3B
6 New Institutional Positions3 Institutional Exits
Vol
Market Cap$1.3B
Cap SizeSmall Cap
Analyst ConsensusBuy (63%)
Inst. Holders50 funds
Inst. Value$159.0M
Inst. Activity6 buys / 3 sells
Insider Activity0B / 2S
Insider Net $-$254.0K
SEC Reports4
Exchange Nasdaq·Sector Pharmaceutical Preparations·Inc. DE·CIK 0001823239·Prev Close $4.96

Recent Activity

Jun 14, 2026 SEC
During Q1 2026, six institutional investors increased their MRVI positions (net +$2.3M) while three trimmed (net -$256K)
INST-CLUSTER — Impact 4/10
Jun 10, 2026 Insider
ORESHACK KURT sold 25,000 shares
General Counsel @ $5.10 ($127.5K)
Jun 9, 2026 Insider
ORESHACK KURT sold 25,000 shares
General Counsel @ $5.06 ($126.5K)
Jun 9, 2026 Insider
LUCIER GREGORY T gifted 46,293 shares
Director
Jun 8, 2026 short_volume
Short Volume: MRVI — 71.2% short (0.7M / 1.0M)
Short: 680,390 | Exempt: 0 | TRF Vol: 954,944 | Short Ratio: 71.2% | Off-exchange volume (dark pool
Jun 3, 2026 SEC
Maravai LifeSciences refinanced its prior credit agreement by entering into a new $150.0 million term loan and $30.0 mil
8-K — Impact 6/10
Apr 28, 2026 SEC
Maravai LifeSciences Holdings, Inc. filed a DEFA14A to add Inline XBRL tagging to its definitive proxy statement for the
DEFA14A — Impact 1/10
Inst.
First Eagle Investment Management, — ADD
2,524,336 shares ($7.1M)

Price Targets

$5.70 +13.8% upside Buy
Current $5.01 Low $5.00 Median $6.00 High $6.00 5 analysts
$5.00 $6.00

Analyst Ratings

Buy63% buy · 16 analysts
4Strong Buy
6Buy
6Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 8, 2026 Wells Fargo MAINTAIN Overweight → Overweight

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.04 ▲ +5.1% $-0.06 — $-0.03 45% YoY 8
Next Q $-0.05 ▲ +5.7% $-0.06 — $-0.03 42% YoY 7
Current FY $-0.11 ▲ +38.0% $-0.17 — $-0.07 60% YoY 8
Next FY $-0.09 ▲ +38.7% $-0.23 — $0.00 19% YoY 8

Latest Reports

MIXED INST-CLUSTER 4/10
During Q1 2026, six institutional investors increased their MRVI positions (net +$2.3M) while three trimmed (net -$256K)
Jun 14, 2026
BULLISH 8-K 6/10
Maravai LifeSciences refinanced its prior credit agreement by entering into a new $150.0 million term loan and $30.0 mil
Jun 3, 2026

Top Institutional Holders

FundValueMove
BlackRock, Inc.$26.4M—
MACKENZIE FINANCIAL CORP$17.8M—
VANGUARD CAPITAL MANAGEMENT LLC$15.4M—
RENAISSANCE TECHNOLOGIES LLC$12.1M—
MORGAN STANLEY$9.4M—

Recent Insider Trades

DateInsiderTypeValue
Jun 10, 2026ORESHACK KURTSELL$127.5K
Jun 9, 2026ORESHACK KURTSELL$126.5K
Jun 9, 2026LUCIER GREGORYG$0.00
Jun 8, 2026Brust BerndF$1.8M
May 26, 2026DeFord JohnA$0.00
50 institutional holders with $159.0M total value (56,176,436 shares) as of 2026-Q1. Top holders: BlackRock,, MACKENZIE, VANGUARD. Net buying activity: 6 institutions added/increased vs 3 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1BlackRock, Inc.9,345,268$26.4M16.6%—
2MACKENZIE FINANCIAL CORP6,306,425$17.8M11.2%—
3VANGUARD CAPITAL MANAGEMENT LLC5,449,702$15.4M9.7%—
4RENAISSANCE TECHNOLOGIES LLC4,264,689$12.1M7.6%—
5MORGAN STANLEY3,319,325$9.4M5.9%—
6Point72 Asset Management, L.P.3,205,496$9.1M5.7%DOUBLED +8597.7%
7First Eagle Investment Management, LLC2,524,336$7.1M4.5%ADD +40.3%
8STATE STREET CORP2,428,717$6.9M4.3%—
9MARSHALL WACE, LLP2,081,334$5.9M3.7%ADD +52.3%
10GOLDMAN SACHS GROUP INC2,020,329$5.7M3.6%—
11ROYCE & ASSOCIATES LP1,808,448$5.1M3.2%ADD +38.0%
12TWO SIGMA INVESTMENTS, LP1,579,840$4.5M2.8%TRIM -27.9%
13CITADEL ADVISORS LLC1,484,319$4.2M2.6%NEAR_EXIT -85.4%
14DIMENSIONAL FUND ADVISORS LP1,418,597$4.0M2.5%ADD +64.8%
15CHARLES SCHWAB INVESTMENT MANAGEMENT INC993,348$2.8M1.8%—
16VANGUARD PORTFOLIO MANAGEMENT LLC952,838$2.7M1.7%—
17DEUTSCHE BANK AG\858,255$2.4M1.5%—
18LAZARD ASSET MANAGEMENT LLC847,799$2.4M1.5%TRIM -33.9%
19VANGUARD FIDUCIARY TRUST CO774,576$2.2M1.4%—
20BANK OF AMERICA CORP /DE/582,211$1.6M1.0%TRIM -51.0%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
First Eagle Investment Management, LLCADD1,799,3362,524,336+40.3%$7.1M2026-Q1
DIMENSIONAL FUND ADVISORS LPADD860,5471,418,597+64.8%$4.0M2026-Q1
AMERIPRISE FINANCIAL INCDOUBLED13,62985,541+527.6%$242.1K2026-Q1
STATE OF WISCONSIN INVESTMENT BOARDTRIM40,90024,240-40.7%$68.6K2026-Q1
FRANKLIN RESOURCES INCTRIM75,70019,497-74.2%$55.2K2026-Q1
STIFEL FINANCIAL CORPADD11,02714,027+27.2%$39.7K2026-Q1
M&T BANK CORPDOUBLED1,23513,358+981.6%$37.8K2026-Q1
Rockefeller Capital Management L.P.DOUBLED1,4347,148+398.5%$20.2K2026-Q1
HRT FINANCIAL LPNEAR_EXIT367,91176,283-79.3%$215.002026-Q1
Point72 Asset Management, L.P.DOUBLED32,7422,847,799+8597.7%$9.3M2025-Q4
MARSHALL WACE, LLPADD1,313,0252,000,278+52.3%$6.5M2025-Q4
First Eagle Investment Management, LLCDOUBLED450,9311,799,336+299.0%$5.8M2025-Q4
LAZARD ASSET MANAGEMENT LLCTRIM1,540,2261,018,718-33.9%$3.3M2025-Q4
TWO SIGMA INVESTMENTS, LPTRIM1,172,248845,408-27.9%$2.7M2025-Q4
BANK OF AMERICA CORP /DE/TRIM1,432,364701,714-51.0%$2.3M2025-Q4
WELLS FARGO & COMPANY/MNADD84,291123,034+46.0%$399.9K2025-Q4
FRANKLIN RESOURCES INCTRIM102,94875,700-26.5%$246.0K2025-Q4
MetLife Investment Management, LLCTRIM58,71443,349-26.2%$140.9K2025-Q4
AMERIPRISE FINANCIAL INCNEAR_EXIT1,606,87813,629-99.2%$44.3K2025-Q4
Mirae Asset Global Investments Co., Ltd.ADD5,5937,047+26.0%$22.9K2025-Q4
NATIONAL BANK OF CANADA /FI/TRIM136101-25.7%$328.002025-Q4
UBS Group AGTRIM3,232,2842,399,212-25.8%$6.9M2025-Q3
ROYCE & ASSOCIATES LPADD1,276,8561,761,764+38.0%$5.1M2025-Q3
BANK OF AMERICA CORP /DE/ADD1,029,6451,432,364+39.1%$4.1M2025-Q3
MARSHALL WACE, LLPDOUBLED322,1101,313,025+307.6%$3.8M2025-Q3
10 unique insiders with 16 transactions. Net insider value: -$254.0K ($0.00 bought, $254.0K sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 10, 2026ORESHACK KURTGeneral CounselSELL25,000$5.10$127.5K
Jun 9, 2026ORESHACK KURTGeneral CounselSELL25,000$5.06$126.5K
Jun 9, 2026LUCIER GREGORY TDirectorGIFT46,293——
Jun 8, 2026Brust BerndChief Executive OfficerTAX W/H351,001$5.02$1.8M
May 26, 2026DeFord John ADirectorAWARD46,293——
May 26, 2026CUNNINGHAM SEAN LAURENCEDirectorAWARD46,293——
May 26, 2026MARKER LUKE JOSEPHDirectorAWARD46,293——
May 26, 2026GRAY SUSANNAHDirectorAWARD46,293——
May 26, 2026MIHAS CONSTANTINE SDirectorAWARD46,293——
May 26, 2026ECKERT R ANDREWDirectorAWARD46,293——
May 26, 2026LUCIER GREGORY TDirectorAWARD46,293$4.38$202.8K
May 26, 2026LUCIER GREGORY TDirectorAWARD46,293——
May 15, 2026Dolan ChristineSee RemarksAWARD5,006$1.79$9.0K
May 15, 2026ORESHACK KURTGeneral CounselAWARD776$2.84$2.2K
Mar 16, 2026ORESHACK KURTGeneral CounselTAX W/H39,976$3.08$123.1K
Mar 16, 2026Dolan ChristineSee RemarksTAX W/H28,661$3.08$88.3K
4 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 2 mixed, 1 neutral. Avg impact: 4.3/10.
MIXED INST-CLUSTER 4/10
During Q1 2026, six institutional investors increased their MRVI positions (net +$2.3M) while three
Jun 14, 2026
BULLISH 8-K 6/10
Maravai LifeSciences refinanced its prior credit agreement by entering into a new $150.0 million ter
Jun 3, 2026
NEUTRAL DEFA14A 1/10
Maravai LifeSciences Holdings, Inc. filed a DEFA14A to add Inline XBRL tagging to its definitive pro
Apr 28, 2026
MIXED 8-K 6/10
Maravai LifeSciences reported full-year 2025 revenue of $185.7 million, down 28.3% year-over-year, d
Feb 25, 2026
∅

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Buy (63% buy). Based on 16 analysts: 4 strong buy, 6 buy, 6 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$5.70 mean target +13.8% upside Buy (1.75)
$5.00 Low $6.00 High
MetricValue
Current Price$5.01
Target Low$5.00
Target Mean$5.70
Target Median$6.00
Target High$6.00
# Analysts5
RecommendationBuy (1.75)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
 $-0.04 $-0.06 $-0.03 45.0% +5.1% 0↑ 1↓ $0.0B 2.7% 8
Next Q
2026-09-30
 $-0.05 $-0.06 $-0.03 41.9% +5.7% 1↑ 0↓ $0.0B 6.3% 7
Current FY
2026-12-31
 $-0.11 $-0.17 $-0.07 60.4% +38.0% 2↑ 0↓ $0.2B 13.3% 8
Next FY
2027-12-31
 $-0.09 $-0.23 $0.00 19.0% +38.7% 2↑ 0↓ $0.2B 7.3% 8

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.044
7d ago$-0.047+0.003
30d ago$-0.046+0.002
60d ago$-0.045+0.001
90d ago$-0.045+0.001
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 8, 2026 Wells Fargo MAINTAIN Overweight Overweight

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20264660063%
May 1, 20264660063%
Apr 1, 20264670059%
Mar 1, 20264670059%
Feb 1, 20264670059%
Jan 1, 20264670059%
Strong BuyBuyHoldSellStrong Sell
∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

∅

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Jun 8, 2026
short_volume
Short Volume: MRVI — 71.2% short (0.7M / 1.0M)
Short: 680,390 | Exempt: 0 | TRF Vol: 954,944 | Short Ratio: 71.2% | Off-exchange volume (dark pool + OTC)
May 7, 2026
earnings_calendar
MRVI Q1 2026 Earnings After Market Close — 2026-05-07
Feb 25, 2026
earnings_calendar
MRVI Q4 2025 Earnings After Market Close — 2026-02-25